- Home
- VRDN vs UWMC Comparison
VRDN vs UWMC Comparison
Compare VRDN & UWMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- UWMC
- Stock Information
- Founded
- VRDN 2006
- UWMC 1986
- Country
- VRDN United States
- UWMC United States
- Employees
- VRDN N/A
- UWMC N/A
- Industry
- VRDN Medical Specialities
- UWMC Finance: Consumer Services
- Sector
- VRDN Health Care
- UWMC Finance
- Exchange
- VRDN Nasdaq
- UWMC Nasdaq
- Market Cap
- VRDN 1.6B
- UWMC 1.4B
- IPO Year
- VRDN N/A
- UWMC N/A
- Fundamental
- Price
- VRDN $21.65
- UWMC $5.98
- Analyst Decision
- VRDN Strong Buy
- UWMC Hold
- Analyst Count
- VRDN 11
- UWMC 8
- Target Price
- VRDN $38.80
- UWMC $6.18
- AVG Volume (30 Days)
- VRDN 658.9K
- UWMC 8.8M
- Earning Date
- VRDN 11-11-2025
- UWMC 11-06-2025
- Dividend Yield
- VRDN N/A
- UWMC 6.70%
- EPS Growth
- VRDN N/A
- UWMC 112.84
- EPS
- VRDN N/A
- UWMC 0.07
- Revenue
- VRDN $305,000.00
- UWMC $2,622,828,000.00
- Revenue This Year
- VRDN N/A
- UWMC $20.67
- Revenue Next Year
- VRDN $34,076.08
- UWMC $7.62
- P/E Ratio
- VRDN N/A
- UWMC $90.14
- Revenue Growth
- VRDN 5.90
- UWMC 13.45
- 52 Week Low
- VRDN $9.90
- UWMC $3.80
- 52 Week High
- VRDN $27.20
- UWMC $8.03
- Technical
- Relative Strength Index (RSI)
- VRDN 66.74
- UWMC 45.99
- Support Level
- VRDN $20.83
- UWMC $5.90
- Resistance Level
- VRDN $19.97
- UWMC $6.31
- Average True Range (ATR)
- VRDN 0.92
- UWMC 0.27
- MACD
- VRDN 0.18
- UWMC -0.11
- Stochastic Oscillator
- VRDN 91.56
- UWMC 7.50
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About UWMC UWM Holdings Corporation
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.